birtamimab,daratumumab,dexamethasone
prothena,lightchain biosciences,janssen
['birtamimab', 'mmsm', ' dara ', 'light chain']
#ash22 #mmsm oral survival benefit of birtamimab in mayo stage iv al amyloidosis phase 3 vital study, mechanism and study design. post-hoc analysis, at month 9 was reported here. prior to dara 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities